GH1 and non-small cell lung carcinoma: Collectively, these findings suggest that GH enhances the migratory and invasive potential of NSCLC cells through activation of GH signaling pathways, while pegvisomant effectively counteracts both exogenous and autocrine GH-induced effects, highlighting its potential role in suppressing tumor progression and metastasis in LC.